Ultrasound study of tendon health in psoriatic arthritis
Part of Bones, joints & muscles, Skin clinical trials.
This study uses ultrasound and a special technique called elastography to look at the health of tendons in people with psoriatic arthritis compared to healthy volunteers. The information may help doctors better understand and manage the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You either have a diagnosis of psoriatic arthritis (according to CASPAR criteria) or you are a healthy volunteer without any inflammatory rheumatic disease.
- If you have psoriatic arthritis, you must not have had any surgery, fracture, major trauma, or tendon rupture in the areas to be examined.
- You must not have had steroid or platelet-rich plasma injections in the areas to be examined within the last 3 months.
- You must be willing to undergo ultrasound and elastography assessments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies people with psoriatic arthritis who have painful Achilles tendon insertion with signs of inflammation on ultrasound. It may help researchers better understand what drives tendon inflammation and how it can be treated.
This study tests whether IL-17 inhibitor medications can reduce inflammation in tendons and ligaments that is not visible on the skin but can be detected with a special ultrasound. It may be an option for people with moderate to severe psoriasis who have not had enough relief from creams or light therapy.
This study uses power Doppler ultrasound to classify and measure how active your psoriatic arthritis is. It may help doctors better understand and treat your condition.
This study looks at how well upadacitinib treats enthesitis (pain where tendons or ligaments attach to bone) in people with psoriatic arthritis. Researchers will use ultrasound to measure improvement. The trial is for adults who have already tried at least one biologic drug, including an anti-TNF, without success.
This study looks at how inflammatory “cytokines” are expressed in people with psoriasis—both those with joint involvement and those without. It may help researchers understand what drives joint disease and guide better future monitoring or treatments.
This trial compares two drugs, apremilast and adalimumab, to see which is more effective for people with psoriatic arthritis who have not responded well to methotrexate. It focuses on joint pain, swelling, and skin symptoms.
Hear when a new Psoriatic Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.